1
72
A . P. Beresford et al.
Cook, J. C. and Hodgson , E., 1985, The induction of cytochrome P-450 by isosafrole and related
methylenedioxyp henol compounds, Chemico-Biological Interactions, 54, 299±315.
Diamond , L. and Gelboin , H. V., 1969, Alpha-naphtho¯ avone: an inhibitor of hydrocarbon cytotoxicity
and microsomal hydroxylase. Science, 166, 1023±1025.
Edwards, R. J., Murray, B. P., Singleton , A. M., Murray, S., Davies , D. S. and Boobis , A. R., 1993,
Identi®cation of the epitope of an anti-peptide antibody which binds to CYP1A2 in many species
including man. Biochemical Pharmacology, 46, 213±220.
Fujii -Kuriyama , Y., Imataka , H., Sogawa, K., Yasumoto , K.- I. and Kikuchi , Y., 1992, Regulation of
CYP1A1 expression. FASEB Journal, 6, 706±710.
Gristwood , W. E., 1990, Determination of ¯ uparoxan (GR50360) in plasma by gas chromatography.
Journal of Chromatography, 527, 436±440.
Halliday , C. A., Jones , B. J., Straughan , D. W., T yers, M. B., Walsh , D. M., Walsh , H. and Wise ,
H., 1988, GR50360, a novel and highly selective a -adrenoceptor antagonist. British Journal of
#
Pharmacology, 95, 751P.
Hankinson , O., 1995, The aryl hydrocarbon receptor complex. Annual Review of Pharmacology and
Toxicology, 35, 307±340.
Ioannides , C., L ewis , D. F. V. and Parke, D. V., 1994, The use of computers in the safety evaluation
of drugs and other chemicals. European Journal of Drug Metabolism and Pharmacokinetics, 3,
2
25±233.
Ioannides , C. and Parke, D. V., 1993, Induction of cytochrome P4501 as an indicator of potential
chemical carcinogenesis. Drug Metabolism Reviews, 25, 485±501.
Johnson , M. A., Blackwell , C. P. and Smith , J., 1995, Antagonism of the eŒects of clonidine by the
a -adrenoceptor antagonist, ¯ uparoxan. British Journal of Clinical Pharmacology, 36, 477±483.
Jorgensen , E. C. B. and Autrup, H., 1996, Autoregulation of human CYP1A1 gene promoter activity
#
in HepG2 and MCF- 7 cells. Carcinogenesis, 17, 435±441.
Kimura , S., Gonzalez, F. J. and Nebert , D. W., 1984, The murine Ah locus. Comparison of the
complete cytochrome P1- 450 and P3- 450 cDNA nucleotide and amino acid sequences. Journal of
Biological Chemistry, 259, 10 705±10 713.
Koch, G. G., 1972, The use of non-parametric methods in the statistical analysis of the two-period
change- over design. Biometrics, 28, 577±584.
L aemmli , U. K., 1970, Change of structural proteins during the assembly of the head of bacteriophage
T4. Nature , 227, 680±685.
L ewis , D. F. V., 1996, Quantitative structure- activity relationships in substrates, inducers and inhibitors
of cytochrome P4501 (CYP1). Drug Metabolism Reviews (in press).
L ewis , D. F. V., M oereels , H., L ake, B. G., Ioannides , C. and Parke, D. V., 1994, Molecular
modeling of enzymes and receptors involved in carcinogenesis : QSARs and COMPACT- 3D.
Drug Metabolism Reviews, 26, 261±285.
! !
L ucas, D., Berthou , F., Dreano, Y., L ozac’ h, P., Volant , A. and Menez, J.- F., 1993, Comparison of
levels of cytochrome P- 450, CYP1A2, CYP2E1, and their related monooxygenase activities in
human surgical liver samples. Alcoholism : Clinical and Experimental Research, 17, 900±905.
M ineshita , S., Eggers, R., Kitteringham , N. R. and Ohnhaus , E. E., 1986, Determination of
phenacetin and its major metabolites in human plasma and urine by high performance liquid
chromatography. Journal of Chromatography, 380, 407±413.
Nash, T., 1953, The colorimetric estimation of formaldehyde by means of the Hantzsch reaction.
Biochemical Journal, 55, 416±421.
Nebert , D. W. and Gonzalez, F. J., 1987, P450 genes : structure, evolution, and regulation. Annual
Review of Biochemistry, 45, 945±993.
Nebert , D. W. and Jones , J. E., 1989, Regulation of the mammalian cytochrome P -450 (CYP1A1) gene.
"
International Journal of Biochemistry, 21, 243±252.
Nebert , D. W., Nelson , D. R., Adesnik , M., Coon , M. J., Estabrook , R. W., Gonzalez, F. J.,
Guengerich , F. P., Gunsalus , I. C., Johnson , E. F., Kemper , B., L evin , W., Phillips , I. R.,
Sato, R. and Waterman , M. R., 1989, The P450 superfamily : updated listing of all genes and
recommended nomenclature for the chromasomal loci. DNA , 8, 1±13.
Nebert , D. W., Puga, A. and Vasiliou , V., 1993, Role of the Ah receptor and the dioxin- inducible [Ah]
gene battery in toxicity, cancer, and signal transduction. Annals of the New York Acadamy of
Science, 685, 624±640.
Nedelcheva , V. and Gut, I., 1994, P450 in the rat and man : methods of investigation, substrate
speci®cities and relevance to cancer. Xenobiotica, 24, 1151±1175.
Nelson , D. R., Koymans , L., Kamataki , T., Stegeman , J. J., Feyereisen , R., W axman , D. J.,
W aterman , M. R., Gotoh , O., Coon , M. J., Estabrook , R. W., Gunsalas , I. C. and Nebert ,
D. W., 1996, P450 superfam ily : update on new sequences, gene mapping, accession numbers
and nomenclature. Pharmacogenetics, 6, 1±42.
Nelson , D. R. and Strobel , H. W., 1987, Evolution of cytochrome P- 450 proteins. Molecular Biology
and Evolution, 4, 572±593.